Table 1 Clinical characteristics and management of KFD patients
From: Macrophage activation syndrome in children with Kikuchi-Fujimoto disease
Without MAS (n = 43) | With MAS (n = 15) | p-value | |
|---|---|---|---|
Demorgraphic Data | |||
Age, years | 8.5 (6.8–11.8) | 10.58 (7.2–12.9) | 0.86 |
Male to female ratio | 1.69 (27:16) | 2.75 (11:4) | 0.54 |
Follow-up (years) | 3.58 (2.33–5.25) | 4.33 (3.0–5.5) | 0.18 |
Clinical manifestations | |||
Fever | 39 (90.7) | 15 (100) | 0.34 |
Hepatomegaly | 14 (32.6) | 5 (33.3) | > 0.9999 |
Splenomegaly | 7 (16.3) | 1 (6.7) | 0.44 |
Skin rash | 1 (2.3) | 4 (26.7) | 0.01 |
Arthralgia/arthritis | 1 (2.3) | 1 (6.7) | > 0.9999 |
Gastrointestinal symptoms | 4 (9.3) | 1 (6.7) | > 0.9999 |
Respiratory symptoms | 4 (9.3) | 3 (20.0) | 0.36 |
Central nervous symptoms | 7 (16.3) | 2 (13.3) | > 0.9999 |